This course has expired. View available courses.
Infectious Disease, Oncology, Women's Health
HPV Testing: Enhanced Screening for Cervical Cancer in Women 30 Years of Age and Older – Mainpro+
Cervical cancer is one of the most common types of human papillomavirus (HPV) associated cancers diagnosed in Canada. There has been a significant decrease in the number of women diagnosed with cervical cancer (26% decline over the last 30 years) due to widespread cervical cancer screening and HPV detection. The numbers to-date confirm the positive effect of cytology testing in screening for cervical cancer but also the need for continued screening.
The fundamental goal of cervical cancer screening and HPV-associated cytology testing is to prevent morbidity and mortality from cervical cancer. Understanding the link between HPV and cancer has changed how this type of cancer is detected. In fact, deaths from cervical cancer in Canada and the U.S. have declined by about 2% a year due to the widespread use of cytology testing. This program examines the role of HPV testing in cervical cancer and particularly in women 30 years of age and over.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
Mainpro+
EXPIRY DATE
2020-01-31
Cervical cancer is one of the most common types of human papillomavirus (HPV) associated cancers diagnosed in Canada. There has been a significant decrease in the number of women diagnosed with cervical cancer (26% decline over the last 30 years) due to widespread cervical cancer screening and HPV detection. The numbers to-date confirm the positive effect of cytology testing in screening for cervical cancer but also the need for continued screening.
The fundamental goal of cervical cancer screening and HPV-associated cytology testing is to prevent morbidity and mortality from cervical cancer. Understanding the link between HPV and cancer has changed how this type of cancer is detected. In fact, deaths from cervical cancer in Canada and the U.S. have declined by about 2% a year due to the widespread use of cytology testing. This program examines the role of HPV testing in cervical cancer and particularly in women 30 years of age and over.
Faculty
Daniel Ngui (BSc, PT, MD, FCFP), Jeff Habert (MD, CCFP, FCFP), Mona Kamel (MD, BCh, FRCPC), Pravinsagar Mehta (MD, CCFP, FCFP)
Learning objectives
Upon completion of this program, participants will be able to:
- Navigate the challenges of managing testosterone deficiency syndrome (TDS) in primary care.
- Differentiate treatment modalities in individualizing treatment of TDS.
- Effectively counsel patients to overcome barriers to treatment adherence in TDS.
Accreditation
#
of credits: 1
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Physician
Profession
1
# of credits
Learning Objectives
Upon completion of this program, participants will be able to:
- Navigate the challenges of managing testosterone deficiency syndrome (TDS) in primary care.
- Differentiate treatment modalities in individualizing treatment of TDS.
- Effectively counsel patients to overcome barriers to treatment adherence in TDS.
Mainpro+
ACCREDITATION
Infectious Disease, Oncology, Women's Health
Learning Category
General
Topic
0
Price
2020-01-31
Expiry Date
CAN-eng
Region/Language
Course Description
Cervical cancer is one of the most common types of human papillomavirus (HPV) associated cancers diagnosed in Canada. There has been a significant decrease in the number of women diagnosed with cervical cancer (26% decline over the last 30 years) due to widespread cervical cancer screening and HPV detection. The numbers to-date confirm the positive effect of cytology testing in screening for cervical cancer but also the need for continued screening.
The fundamental goal of cervical cancer screening and HPV-associated cytology testing is to prevent morbidity and mortality from cervical cancer. Understanding the link between HPV and cancer has changed how this type of cancer is detected. In fact, deaths from cervical cancer in Canada and the U.S. have declined by about 2% a year due to the widespread use of cytology testing. This program examines the role of HPV testing in cervical cancer and particularly in women 30 years of age and over.
Faculty
Daniel Ngui (BSc, PT, MD, FCFP), Jeff Habert (MD, CCFP, FCFP), Mona Kamel (MD, BCh, FRCPC), Pravinsagar Mehta (MD, CCFP, FCFP)
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ Credit(s). Cert+ Program ID#: 189239
1 hr
Duration
0
Price
1
# of credits
